FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns the use of 12-imidazolyl-1-dodecanol for making a pharmaceutical composition for prevention and treatment of cancer, as well as a pharmaceutical composition for prevention and treatment of cancer containing 12-imidazolyl-1-dodecanol in a pharmaceutically acceptable carrier.
EFFECT: invention provides higher clinical effectiveness.
3 cl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF COMPOUNDS OF FORMULA A-R-X OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARING PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2477275C1 |
| DEUTERATED 3-PIPERIDINOETHYLPHENYLKETONES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2002 |
|
RU2296755C2 |
| TREATING OR PREVENTING PROLIFERATIVE CONDITIONS | 2010 |
|
RU2705548C2 |
| DERIVATIVES OF THIAZOLOQUINOLINE, THEIR RACEMATES OR SEPARATE ENANTIOMERS AND PHARMACEUTICALLY ACCEPTABLE HYDRATES OR SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 1995 |
|
RU2138505C1 |
| PHARMACEUTICAL COMPOSITION, METHOD OF ITS PREPARING AND METHOD OF INCREASE OF AN ACTIVE SUBSTANCE BIOLOGICAL AVAILABILITY USING THIS COMPOSITION | 1991 |
|
RU2104715C1 |
| PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2690377C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MODIFIED CARRIER | 2003 |
|
RU2401127C2 |
| FUEL COMPOSITIONS CONTAINING RAW MATERIAL OF PLANT ORIGIN | 2007 |
|
RU2441902C2 |
| HETEROCYCLYL-BENZOYLGUANIDINES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2152390C1 |
| LYSINE-RELATED DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS | 2007 |
|
RU2458916C2 |
